The Valley Desk

NCT00456508 · Interventional trial

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Overall registry status Completed

Phase 3

Conditions Hereditary Angioedema (HAE)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov